The complexity of sporadic Alzheimer's disease pathogenesis: The role of RAGE as therapeutic target to promote neuroprotection by inhibiting neurovascular dysfunction

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Perrone, Lorena ^a   Sbai, Oualid ^a   Nawroth, Peter P ^b   Bierhaus, Angelika ^b  

^a CNRS   (France)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPROTECTIVE AGENT; PF 04494700; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

AGING; ALZHEIMER DISEASE; BRAIN DYSFUNCTION; DRUG TARGETING; GLIA CELL; HUMAN; INFLAMMATION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION;

EID: 84859761969     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/734956     Document Type: Review

References (103)

1. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 5580 353 356 (Pubitemid 34790756)
2. Kern A., Behl C., The unsolved relationship of brain aging and late-onset Alzheimer disease Biochimica et Biophysica Acta 2009 1790 1124 1232
3. Qiu C., Kivipelto M., Von Strauss E., Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention Dialogues in Clinical Neuroscience 2009 11 2 111 128
4. Recuero M., Vicente M. C., Martnez-Garca A., Ramos M. C., Carmona-Ssaez P., Sastre I., Aldudo J., Vilella E., Frank A., Bullido M. J., Valdivieso F., A free radical-generating system induces the cholesterol biosynthesis pathway: a role in Alzheimer's disease Aging Cell 2009 8 2 128 139
5. Faller P., Copper and zinc binding to amyloid- : coordination, dynamics, aggregation, reactivity and metal-ion transfer ChemBioChem 2009 10 18 2837 2845
6. Perrone L., Mothes E., Vignes M., Mockel A., Figueroa C., Miquel M. C., Maddelein M. L., Faller P., Copper transfer from Cu-A to human serum albumin inhibits aggregation, radical production and reduces A toxicity ChemBioChem 2010 11 1 110 118
7. Lesné S., Kotilinek L., Ashe K. H., Plaque-bearing mice with reduced levels of oligomeric amyloid- assemblies have intact memory function Neuroscience 2008 151 3 745 749
8. Selkoe D. J., Soluble oligomers of the amyloid -protein impair synaptic plasticity and behavior Behavioural Brain Research 2008 192 1 106 113
9. Bierhaus A., Nawroth P. P., The Alzheimer's disease-diabetes angle: inevitable fate of aging or metabolic imbalance limiting successful aging Journal of Alzheimer's Disease 2009 16 4 673 675
10. Takeda S., Sato N., Uchio-Yamada K., Sawada K., Kunieda T., Takeuchi D., Kurinami H., Shinohara M., Rakugi H., Morishita R., Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A deposition in an Alzheimer mouse model with diabetes Proceedings of the National Academy of Sciences of the United States of America 2010 107 15 7036 7041
11. Valente T., Gella A., Fernndez-Busquets X., Unzeta M., Durany N., Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus Neurobiology of Disease 2010 37 1 67 76
12. Bierhaus A., Hofmann M. A., Ziegler R., Nawroth P. P., AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept Cardiovascular Research 1998 37 3 586 600 (Pubitemid 28231153)
13. Rahmadi A., Steiner N., Mnch G., Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease Clinical Chemistry and Laboratory Medicine 2011 49 3 385 391
14. Loske C., Gerdemann A., Schepl W., Wycislo M., Schinzel R., Palm D., Riederer P., Mnch G., Transition metal-mediated glycoxidation accelerates cross-linking of -amyloid peptide European Journal of Biochemistry 2000 267 13 4171 4178 (Pubitemid 30436113)
15. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A., Advanced glycation end products contribute to amyloidosis in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1994 91 11 4766 4770 (Pubitemid 24177730)
16. Guglielmotto M., Aragno M., Tamagno E., Vercellinatto I., Visentin S., Medana C., Catalano M. G., Smith M. A., Perry G., Danni O., Boccuzzi G., Tabaton M., AGEs/RAGE complex upregulates BACE1 via NF- B pathway activation Neurobiology of Aging 2012 33 1 196.e13 196.e27
17. Bierhaus A., Humpert P. M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D. M., Nawroth P. P., Understanding RAGE, the receptor for advanced glycation end products Journal of Molecular Medicine 2005 83 11 876 886 (Pubitemid 41598688)
18. Bierhaus A., Nawroth P. P., Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications Diabetologia 2009 52 11 2251 2263
19. Yan S. D., Roher A., Chaney M., Zlokovic B., Schmidt A. M., Stern D., Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid -peptide Biochimica et Biophysica Acta 2000 1502 1 145 157 (Pubitemid 30433864)
20. Schmidt A. M., Sahagan B., Nelson R. B., Selmer J., Rothlein R., Bell J. M., The role of RAGE in amyloid- peptide-mediated pathology in Alzheimer's disease Current Opinion in Investigational Drugs 2009 10 7 672 680
21. Shi D. Y., Bierhaus A., Nawroth P. P., Stern D. M., RAGE and Alzheimer's disease: a progression factor for amyloid- -induced cellular perturbation? Journal of Alzheimer's Disease 2009 16 4 833 843
22. Deane R., Bell R. D., Sagare A., Zlokovic B. V., Clearance of amyloid- peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease CNS and Neurological DisordersDrug Targets 2009 8 1 16 30
23. Deane R., Yan S. D., Submamaryan R. K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A. M., Armstrong D. L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B., RAGE mediates amyloid- peptide transport across the blood-brain barrier and accumulation in brain Nature Medicine 2003 9 7 907 913 (Pubitemid 36889934)
24. Deane R., Zlokovic B. V., Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease Current Alzheimer Research 2007 4 2 191 197 (Pubitemid 46562394)
25. Daborg J., Von Otter M., Sjlander A., Nilsson S., Minthon L., Gustafson D. R., Skoog I., Blennow K., Zetterberg H., Association of the RAGE G82S polymorphism with Alzheimer's disease Journal of Neural Transmission 2010 117 7 861 867
26. Perrone L., Devi T. S., Hosoya K. I., Terasaki T., Singh L. P., Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions Journal of Cellular Physiology 2009 221 1 262 272
27. Sbai O., Devi T. S., Melone M. A. B., Feron F., Khrestchatisky M., Singh L. P., Perrone L., RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion Journal of Cell Science 2010 123 24 4332 4339
28. Kim S. Y., Suh H. W., Chung J. W., Yoon S. R., Choi I., Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases Cellular molecular immunology 2007 4 5 345 351
29. Marcon G., Tell G., Perrone L., Garbelli R., Quadrifoglio F., Tagliavini F., Giaccone G., APE1/Ref-1 in Alzheimer's disease: an immunohistochemical study Neuroscience Letters 2009 466 3 124 127
30. Perrone L., Devi T. S., Hosoya K. I., Terasaki T., Singh L. P., Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions Journal of Cellular Physiology 2010 221 1 262 272
31. Yamawaki H., Pan S., Lee R. T., Berk B. C., Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells Journal of Clinical Investigation 2005 115 3 733 738 (Pubitemid 40322249)
32. Aon-Bertolino M. L., Romero J. I., Galeano P., Holubiec M., Badorrey M. S., Saraceno G. E., Hanschmann E. M., Lillig C. H., Capani F., Thioredoxin and glutaredoxin system proteins-immunolocalization in the rat central nervous system Biochimica et Biophysica Acta 2011 1810 1 93 110
33. Craft S., Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment Current Alzheimer Research 2007 4 2, article 21 147 152 (Pubitemid 46557503)
34. Chutkow W. A., Birkenfeld A. L., Brown J. D., Lee H. Y., Frederick D. W., Yoshioka J., Patwari P., Kursawe R., Cushman S. W., Plutzky J., Shulman G. I., Samuel V. T., Lee R. T., Deletion of the -arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity Diabetes 2010 59 6 1424 1434
35. Wang L., Li S., Jungalwala F. B., Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth Journal of Neuroscience Research 2008 86 6 1254 1266 (Pubitemid 351571900)
36. Harman D., The aging process Proceedings of the National Academy of Sciences of the United States of America 1981 78 11 7124 7128
37. Beckman K. B., Ames B. N., The free radical theory of aging matures Physiological Reviews 1998 78 2 547 581 (Pubitemid 28182903)
38. Fleming T. H., Humpert P. M., Nawroth P. P., Bierhaus A., Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging processa mini-review Gerontology 2010 57 5
39. Butterfield D. A., Sultana R., Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder Journal of Alzheimer's Disease 2007 12 1 61 72 (Pubitemid 47396301)
40. Smith C. D., Carney J. M., Tatsumo T., Stadtman E. R., Floyd R. A., Markesbery W. R., Protein oxidation in aging brain Annals of the New York Academy of Sciences 1992 663 110 119 (Pubitemid 23090529)
41. Lovell M. A., Xie C., Markesbery W. R., Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures Neurobiology of Aging 2001 22 2 187 194 (Pubitemid 32162967)
42. Markesbery W. R., Lovell M. A., Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiology of Aging 1998 19 1 33 36 (Pubitemid 28167792)
43. Bierhaus A., Nawroth P. P., Posttranslational modification of lipoproteinsa fatal attraction in metabolic disease? Commentary on: Hone et al., Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding Journal of Alzheimer's Disease 2005 7 4 315 317 (Pubitemid 41206943)
44. Thornalley P. J., Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapy Biochemical Society Transactions 2003 31 6 1372 1377 (Pubitemid 38030979)
45. Srikanth V., Maczurek A., Phan T., Steele M., Westcott B., Juskiw D., Mnch G., Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease Neurobiology of Aging 2011 32 5 763 777
46. Horie K., Miyata T., Yasuda T., Takeda A., Yasuda Y., Maeda K., Sobue G., Kurokawa K., Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons Biochemical and Biophysical Research Communications 1997 236 2 327 332 (Pubitemid 27373293)
47. Bierhaus A., Schiekofer S., Schwaninger M., Andrassy M., Humpert P. M., Chen J., Hong M., Luther T., Henle T., Klting I., Morcos M., Hofmann M., Tritschler H., Weigle B., Kasper M., Smith M., Perry G., Schmidt A. M., Stern D. M., Hring H. U., Schleicher E., Nawroth P. P., Diabetes-associated sustained activation of the transcription factor nuclear factor- B Diabetes 2001 50 12 2792 2808 (Pubitemid 33733131)
48. Mattson M. P., Camandola S., NF- B in neuronal plasticity and neurodegenerative disorders Journal of Clinical Investigation 2001 107 3 247 254
49. Hori O., Brett J., Slattery T., Cao R., Zhang J., Jing Xian Chen, Nagashima M., Lundh E. R., Vijay S., Nitecki D., Morser J., Stern D., Schmidt A. M., The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system Journal of Biological Chemistry 1995 270 43 25752 25761
50. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A. M., RAGE and amyloid- peptide neurotoxicity in Alzheimer's disease Nature 1996 382 6593 685 691 (Pubitemid 26282167)
51. Anzilotti S., Giamp C., Laurenti D., Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease Brain Research Bulletin 2012 87 2-3 350 358
52. Li X.-H., Lv B.-L., Xie J.-Z., Liu J., Zhou X.-W., Wang J.-Z., AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation. Neurobiology of Aging. In press
53. Shi Du Yan, Shi Fang Yan, Chen X., Fu J., Chen M., Kuppusamy P., Smith M. A., Perry G., Godman G. C., Nawroth P., Zweier J. L., Stern D., Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid -peptide Nature Medicine 1995 1 7 693 699
54. Cho H. J., Son S. M., Jin S. M., Hong H. S., Shin D. H., Kim S. J., Huh K., Mook-Jung I., RAGE regulates BACE1 and A generation via NFAT1 activation in Alzheimer's disease animal model FASEB Journal 2009 23 8 2639 2649
55. Mucke L., Masliah E., Yu G. Q., Mallory M., Rockenstein E. M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L., High-level neuronal expression of A (142) in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation Journal of Neuroscience 2000 20 11 4050 4058 (Pubitemid 30365675)
56. Arancio O., Zhang H. P., Chen X., Lin C., Trinchese F., Puzzo D., Liu S., Hegde A., Yan S. F., Stern A., Luddy J. S., Lue L. F., Walker D. G., Roher A., Buttini M., Mucke L., Li W., Schmidt A. M., Kindy M., Hyslop P. A., Stern D. M., Yan S. S. D., RAGE potentiates A -induced perturbation of neuronal function in transgenic mice EMBO Journal 2004 23 20 4096 4105 (Pubitemid 39472430)
57. Origlia N., Righi M., Capsoni S., Cattaneo A., Fang F., Stern D. M., Chen J. X., Schmidt A. M., Arancio O., Shi D. Y., Domenici L., Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid- -mediated cortical synaptic dysfunction Journal of Neuroscience 2008 28 13 3521 3530 (Pubitemid 351469321)
58. Origlia N., Arancio O., Domenici L., Yan S. S., MAPK, -amyloid and synaptic dysfunction: the role of RAGE Expert Review of Neurotherapeutics 2009 9 11 1635 1645
59. Origlia N., Capsoni S., Cattaneo A., Fang F., Arancio O., Yan S. D., Domenici L., A -dependent inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE Journal of Alzheimer's Disease 2009 17 1 59 68
60. Vodopivec I., Galichet A., Knobloch M., Bierhaus A., Heizmann C. W., Nitsch R. M., RAGE does not affect amyloid pathology in transgenic arcA mice Neurodegenerative Diseases 2009 6 5-6 270 280
61. Kuhla B., Loske C., Garcia De Arriba S., Schinzel R., Huber J., Mnch G., Differential effects of "Advanced glycation endproducts" and -amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y Journal of Neural Transmission 2004 111 3 427 439 (Pubitemid 38316614)
62. Cuevas E., Lantz S. M., Tobon-Velasco C., On the in vivo early toxic properties of A 2535 peptide in the rat hippocampus: involvement of the receptor-for-advanced glycation-end-products and changes in gene expression Neurotoxicology and Teratology 2011 33 2 288 296
63. Takuma K., Fang F., Zhang W., Yan S., Fukuzaki E., Du H., Sosunov A., McKhann G., Funatsu Y., Nakamichi N., Nagai T., Mizoguchi H., Ibi D., Hori O., Ogawa S., Stern D. M., Yamada K., Yan S. S., RAGE-mediated signaling contributes to intraneuronal transport of amyloid- and neuronal dysfunction Proceedings of the National Academy of Sciences of the United States of America 2009 106 47 20021 20026
64. Chou D. K. H., Zhang J., Smith F. I., McCaffery P., Jungalwala F. B., Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration Journal of Neurochemistry 2004 90 6 1389 1401 (Pubitemid 39223642)
65. Huttunen H. J., Fages C., Rauvala H., Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF- B require the cytoplasmic domain of the receptor but different downstream signaling pathways Journal of Biological Chemistry 1999 274 28 19919 19924
66. Huttunen H. J., Kuja-Panula J., Rauvala H., Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation Journal of Biological Chemistry 2002 277 41 38635 38646 (Pubitemid 35154724)
67. Huttunen H. J., Kuja-Panula J., Sorci G., Agneletti A. L., Donato R., Rauvala H., Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation Journal of Biological Chemistry 2000 275 51 40096 40105 (Pubitemid 32064635)
68. Sajithlal G., Huttunen H., Rauvala H., Mnch G., Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells Journal of Biological Chemistry 2002 277 9 6888 6897 (Pubitemid 34953073)
69. Srikrishna G., Huttunen H. J., Johansson L., Weigle B., Yamaguchi Y., Rauvala H., Freeze H. H., N-glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth Journal of Neurochemistry 2002 80 6 998 1008 (Pubitemid 34809952)
70. Ling L. R., Trojaborg W., Qu W., Kostov K., Shi D. Y., Gooch C., Szabolcs M., Hays A. P., Schmidt A. M., Antagonism of RAGE suppresses peripheral nerve regeneration FASEB Journal 2004 18 15 1812 1817 (Pubitemid 39602267)
71. Rong L. L., Yan S. F., Wendt T., RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways FASEB Journal 2004 18 15 1818 1825 (Pubitemid 39602268)
72. Fuller S., Steele M., Mnch G., Activated astroglia during chronic inflammation in Alzheimer's disease-do they neglect their neurosupportive roles? Mutation Research 2010 690 1-2 40 49
73. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P., Grubeck-Loebenstein B., How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes Aging Cell 2004 3 4 169 176 (Pubitemid 40253499)
74. Weninger S. C., Yankner B. A., Inflammation and Alzheimer disease: the good, the bad, and the ugly Nature Medicine 2001 7 5 527 528 (Pubitemid 32448307)
75. Bierhaus A., Stern D. M., Nawroth P. P., RAGE in inflammation: a new therapeutic target? Current Opinion in Investigational Drugs 2008 7 11 985 991
76. Mohamed A. K., Bierhaus A., Schiekofer S., Tritschler H., Ziegler R., Nawroth P. P., The role of oxidative stress and NF- B activation in late diabetic complications BioFactors 1999 10 2-3 157 167 (Pubitemid 29533824)
77. Yan S. D., Zhu H., Fu J., Yan S. F., Roher A., Tourtellotte W. W., Rajavashisth T., Chen X., Godman G. C., Stern D., Schmidt A. M., Amyloid- peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1997 94 10 5296 5301 (Pubitemid 27214777)
78. Fang, Lue L. F., Yan S., Xu H., Luddy J. S., Chen D., Walker D. G., Stern D. M., Yan S., Schmidt A. M., Chen J. X., Yan S. S., RAGE-dependent signaling in microglia contributes to neuroinflammation, A accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease FASEB Journal 2010 24 4 1043 1055
79. Origlia N., Bonadonna C., Rosellini A., Leznik E., Arancio O., Yan S. S., Domenici L., Microglial receptor for advanced glycation end product-dependent signal pathway drives -amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex Journal of Neuroscience 2010 30 34 11414 11425
80. Desai B. S., Schneider J. A., Li J. L., Carvey P. M., Hendey B., Evidence of angiogenic vessels in Alzheimer's disease Journal of Neural Transmission 2009 116 5 587 597
81. Ujiie M., Dickstein D. L., Carlow D. A., Jefferies W. A., Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model Microcirculation 2003 10 6 463 470 (Pubitemid 39004272)
82. Farrall A. J., Wardlaw J. M., Blood-brain barrier: ageing and microvascular diseasesystematic review and meta-analysis Neurobiology of Aging 2009 30 3 337 352
83. Malm T., Koistinaho M., Muona A., Magga J., Koistinaho J., The role and therapeutic potential of monocytic cells in Alzheimer's disease GLIA 2010 58 8 889 900
84. Giri R., Selvaraj S., Miller C. A., Hofman F., Yan S. D., Stern D., Zlokovic B. V., Kalra V. K., Effect of endothelial cell polarity on -amyloid-induced migration of monocytes across normal and AD endothelium American Journal of Physiology 2002 283 3 C895 C904 (Pubitemid 34920322)
85. Watson G. S., Craft S., Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis Journal of the Neurological Sciences 2006 245 1-2 21 33 (Pubitemid 43775944)
86. Ke Y. D., Delerue F., Gladbach A., Gtz J., Ittner L. M., Experimental diabetes mellitus exacerbates Tau pathology in a transgenic mouse model of Alzheimer's disease PLoS ONE 2009 4 11, article e7917
87. Turturro F., Friday E., Welbourne T., Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231 BMC Cancer 2007 7, article 96
88. Muoio D. M., TXNIP links redox circuitry to glucose control Cell Metabolism 2007 5 6 412 414 (Pubitemid 46825503)
89. Parikh H., Carlsson E., Chutkow W. A., Johansson L. E., Storgaard H., Poulsen P., Saxena R., Ladd C., Schulze P. C., Mazzini M. J., Jensen C. B., Krook A., Bjrnholm M., Tornqvist H., Zierath J. R., Ridderstrle M., Altshuler D., Lee R. T., Vaag A., Groop L. C., Mootha V. K., TXNIP regulates peripheral glucose metabolism in humans PLoS Medicine 2007 4 5, article e158
90. Mousa S. A., Gallati C., Simone T., Dier E., Yalcin M., Dyskin E., Thangirala S., Hanko C., Rebbaa A., Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions Aging 2009 1 4 412 424
91. Blouet C., Schwartz G. J., Nutrient-sensing hypothalamic TXNIP links nutrient excess to energy imbalance in mice Journal of Neuroscience 2011 31 16 6019 6027
92. Levendusky M. C., Basle J., Chang S., Mandalaywala N. V., Voigt J. M., Dearborn R. E. Jr. , Expression and regulation of vitamin D3 upregulated protein 1 (VDUP1) is conserved in mammalian and insect brain Journal of Comparative Neurology 2009 517 5 581 600
93. Saitoh T., Tanaka S., Koike T., Rapid induction and Ca2+ influx-mediated suppression of vitamin D3 up-regulated protein 1 (VDUP1) mRNA in cerebellar granule neurons undergoing apoptosis Journal of Neurochemistry 2001 78 6 1267 1276 (Pubitemid 32899758)
94. Papadia S., Soriano F. X., Léveillé F., Martel M. A., Dakin K. A., Hansen H. H., Kaindl A., Sifringer M., Fowler J., Stefovska V., Mckenzie G., Craigon M., Corriveau R., Ghazal P., Horsburgh K., Yankner B. A., Wyllie D. J. A., Ikonomidou C., Hardingham G. E., Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses Nature Neuroscience 2008 11 4 476 487 (Pubitemid 351441886)
95. Decker H., Jrgensen S., Adrover M. F., Brito-Moreira J., Bomfim T. R., Klein W. L., Epstein A. L., De Felice F. G., Jerusalinsky D., Ferreira S. T., N-Methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid- peptide oligomers Journal of Neurochemistry 2010 115 6 1520 1529
96. Oakley H., Cole S. L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R., Intraneuronal -amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation Journal of Neuroscience 2006 26 40 10129 10140 (Pubitemid 44527407)
97. Faria A., Pestana D., Teixeira D., Azevedo J., De Freitas V., Mateus N., Calhau C., Flavonoid transport across RBE4 cells: a blood-brain barrier model Cellular and Molecular Biology Letters 2010 15 2 234 241
98. Perrone L., Peluso G., Melone M. A. B., RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes Journal of Cellular Physiology 2008 217 1 60 71
99. World C., Spindel O. N., Berk B. C., Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor- : a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 8 1890 1897
100. Xiong F., Leonov S., Howard A. C., Xiong S., Zhang B., Mei L., McNeil P., Simon S., Xiong W.-C., Receptor for Advanced Glycation End products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a -catenin-dependent manner Journal of Biological Chemistry 2011 286 40 35061 35070
101. Sabbagh M. N., Agro A., Bell J., Aisen P. S., Schweizer E., Galasko D., PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease Alzheimer Disease amp; Associated Disorders 2011 25 3 206 212
102. Cassese A., Esposito I., Fiory F., Barbagallo A. P. M., Paturzo F., Mirra P., Ulianich L., Giacco F., Iadicicco C., Lombardi A., Oriente F., Van Obberghen E., Beguinot F., Formisano P., Miele C., In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs Journal of Biological Chemistry 2008 283 52 36088 36099
103. Koenen T. B., Stienstra R., Van Tits L. J., De Graaf J., Stalenhoef A. F.H., Joosten L. A.B., Tack C. J., Netea M. G., Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1 transcription in human adipose tissue Diabetes 2011 60 2 517 524